eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | severe pre-eclampsia |
| Comorbidity | C0020538|hypertension |
| Sentences | 7 |
| PubMedID- 24958504 | Analysis of urinary markers revealed higher excretion of albumin and kidney injury molecule-1 and lower excretion of neutrophil gelatinase-associated lipocalin and epithelial growth factor in severe preeclampsia compared with chronic hypertension and healthy controls. |
| PubMedID- 22380763 | Results: there were statistically significant differences between the groups when comparing severe preeclampsia with chronic hypertension, and severe preeclampsia with the control group (p < 0.0001). |
| PubMedID- 23657513 | Results: there were significant differences between the groups in comparing severe preeclampsia with chronic hypertension and severe preeclampsia with controls (p < 0.0001 for both measurements). |
| PubMedID- 21298203 | Guidelines for the treatment of hypertension associated with severe pre-eclampsia and eclampsia are provided by the national health department. |
| PubMedID- 21966796 | The most common mother complication was type renovascular hypertension with added severe preeclampsia, which determined the presence of intrauterine growth restriction. |
| PubMedID- 24643210 | Severe hypertension, a feature of severe pre-eclampsia and preexisting hypertension [19, 20], and advanced maternal age [24] are associated with adverse neonatal outcomes because these mothers are prone to abruptio placenta, preterm delivery and neonatal deaths. |
| PubMedID- 26000015 | Captopril can be used safely and effectively in managing postpartum hypertension in women with severe preeclampsia [31]. |
Page: 1